Operating within a live and fully designed platform, I collaborated with Art Director Josh Williams to integrate new strategic directives and optimize existing OFEV elements while implementing Nerandomilast guidance. UX Designer Crysta Jones and I designed intuitive interaction patterns and integrated clear directional guidance towards nerandomilast.com within the OFEV forms, facilitated patient discovery of additional treatment options and ensured a smooth, informed user journey.

Within the OFEV Figma, I focused on enhancing the efficiency and scalability of the design system. Boehringer Ingelheim's Figma design files lacked local components — this deficiency has led to inefficient, manual updates, introduced design inconsistencies across different pages and states, and impeded design scalability and project velocity. To address this, I undertook creating and implementing a comprehensive suite of dedicated OFEV local components. This involved an exhaustive audit of existing UI elements, their standardization into reusable components with defined states and properties, and their integration into the current design files.

This strategic overhaul not only ensured robust design consistency for both new feature development and existing designs but also improved the maintainability and adaptability of these critical digital assets within the broader Global Design System (GDS). By establishing this more structured and component-driven workflow, future design iterations are streamlined with accelerated developer handoff, and fosters a more consistent and reliable user experience across the entire OFEV digital ecosystem.